Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis—a meta-analysis of comparative and non-comparative clinical trials
J Zwang, PL Olliaro - PLoS neglected tropical diseases, 2014 - journals.plos.org
Background Extensive use of praziquantel for treatment and control of schistosomiasis
requires a comprehensive understanding of efficacy and safety of various doses for different …
requires a comprehensive understanding of efficacy and safety of various doses for different …
Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis
R Liu, HF Dong, Y Guo, QP Zhao, MS Jiang - Parasites & vectors, 2011 - Springer
Background Praziquantel has been used as first-line drug for chemotherapy of
schistosomiasis since 1984. Besides praziquantel, artemether and artesunate have also …
schistosomiasis since 1984. Besides praziquantel, artemether and artesunate have also …
Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review
Background Controversy persists about the optimal approach to drug-based control of
schistosomiasis in high-risk communities. In a systematic review of published studies, we …
schistosomiasis in high-risk communities. In a systematic review of published studies, we …
Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis
J Zwang, P Olliaro - Parasites & vectors, 2017 - Springer
Background Children carry most of the schistosomiasis burden. While school-aged children
are the principal target group of preventive chemotherapy with praziquantel, limited …
are the principal target group of preventive chemotherapy with praziquantel, limited …
Application of nanotechnologies for improved immune response against infectious diseases in the developing world
M Look, A Bandyopadhyay, JS Blum… - Advanced drug delivery …, 2010 - Elsevier
There is an urgent need for new strategies to combat infectious diseases in developing
countries. Many pathogens have evolved to elude immunity and this has limited the utility of …
countries. Many pathogens have evolved to elude immunity and this has limited the utility of …
History of schistosomiasis epidemiology, current status, and challenges in China: on the road to schistosomiasis elimination
LG Song, XY Wu, M Sacko, ZD Wu - Parasitology research, 2016 - Springer
Schistosomiasis is a snail-borne disease caused by worms of the genus Schistosoma.
Worldwide, human schistosomiasis remains a serious public health problem, threatening∼ …
Worldwide, human schistosomiasis remains a serious public health problem, threatening∼ …
Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review
M Kabuyaya, MJ Chimbari, S Mukaratirwa - Infectious diseases of poverty, 2018 - Springer
Background Schistosomiasis is a serious public health burden in sub-Saharan Africa.
Praziquantel is the only drug recommended by the World Health Organization to treat both …
Praziquantel is the only drug recommended by the World Health Organization to treat both …
Distribution of schistosomiasis and soil transmitted helminthiasis in Zimbabwe: towards a national plan of action for control and elimination
N Midzi, T Mduluza, MJ Chimbari… - PLoS neglected …, 2014 - journals.plos.org
Background Schistosomiasis and STH are among the list of neglected tropical diseases
considered for control by the WHO. Although both diseases are endemic in Zimbabwe, no …
considered for control by the WHO. Although both diseases are endemic in Zimbabwe, no …
Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy
M Fukushige, M Chase-Topping… - PLoS Neglected …, 2021 - journals.plos.org
Background The antihelminthic drug praziquantel has been used as the drug of choice for
treating schistosome infection for more than 40 years. Although some epidemiological …
treating schistosome infection for more than 40 years. Although some epidemiological …
Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children
Background Several infectious diseases and therapeutic interventions cause gut microbe
dysbiosis and associated pathology. We characterised the gut microbiome of children …
dysbiosis and associated pathology. We characterised the gut microbiome of children …